Nimesulide

CHEMBL56367 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

308.3 g/mol

LogP

2.6

Phase

4

A nonsteroidal anti-inflammatory drug that reduces pain and inflammation by blocking enzymes involved in the production of inflammatory chemicals.

Masse moléculaire

308,3100 g/mol

LogP

2,60

TPSA

110,00 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pain Management Breast Cancer Chronic Pain Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1

InChI

InChI=1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3

Molecular Formula

C13H12N2O5S

HBD / HBA

1 / 6

Liaisons Rotatives

4

Atomes Lourds

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A nonsteroidal anti-inflammatory drug that reduces pain and inflammation by blocking enzymes involved in the production of inflammatory chemicals.

Yes, Nimesulide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL56367. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4495. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Nimesulide sur PillFYI

Structure

Données Clés

Formule: C13H12N2O5S

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.